Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 08, 2023

BUY
$6.71 - $11.83 $49,654 - $87,542
7,400 Added 8.04%
99,400 $666,000
Q2 2023

Aug 09, 2023

BUY
$11.12 - $22.2 $11,120 - $22,200
1,000 Added 1.1%
92,000 $1.05 Million
Q1 2023

May 10, 2023

SELL
$18.7 - $23.07 $196,350 - $242,235
-10,500 Reduced 10.34%
91,000 $1.83 Million
Q4 2022

Feb 08, 2023

BUY
$18.12 - $27.32 $34,428 - $51,908
1,900 Added 1.91%
101,500 $2.3 Million
Q3 2022

Nov 09, 2022

BUY
$16.98 - $25.54 $27,168 - $40,864
1,600 Added 1.63%
99,600 $1.87 Million
Q2 2022

Aug 09, 2022

BUY
$13.15 - $20.45 $210,400 - $327,200
16,000 Added 19.51%
98,000 $1.83 Million
Q1 2022

May 09, 2022

BUY
$14.54 - $21.5 $82,878 - $122,550
5,700 Added 7.47%
82,000 $1.48 Million
Q3 2021

Nov 08, 2021

BUY
$26.01 - $38.22 $70,227 - $103,194
2,700 Added 3.67%
76,300 $2.44 Million
Q2 2021

Aug 06, 2021

SELL
$29.97 - $37.17 $80,919 - $100,359
-2,700 Reduced 3.54%
73,600 $2.27 Million
Q1 2021

May 07, 2021

BUY
$29.24 - $42.03 $29,240 - $42,030
1,000 Added 1.33%
76,300 $2.57 Million
Q3 2020

Nov 09, 2020

BUY
$35.98 - $47.66 $79,156 - $104,851
2,200 Added 3.01%
75,300 $2.77 Million
Q2 2020

Aug 05, 2020

BUY
$45.06 - $67.74 $243,324 - $365,796
5,400 Added 7.98%
73,100 $3.29 Million
Q1 2020

May 08, 2020

BUY
$40.01 - $73.97 $88,022 - $162,734
2,200 Added 3.36%
67,700 $3.21 Million
Q4 2019

Feb 06, 2020

BUY
$37.13 - $74.62 $51,982 - $104,468
1,400 Added 2.18%
65,500 $4.69 Million
Q3 2019

Nov 12, 2019

BUY
$39.36 - $76.8 $456,576 - $890,880
11,600 Added 22.1%
64,100 $2.52 Million
Q2 2019

Aug 02, 2019

BUY
$52.76 - $82.19 $437,908 - $682,177
8,300 Added 18.78%
52,500 $4.1 Million
Q1 2019

May 10, 2019

BUY
$27.39 - $68.41 $41,085 - $102,615
1,500 Added 3.51%
44,200 $2.64 Million
Q4 2018

Feb 13, 2019

BUY
$22.8 - $33.93 $38,760 - $57,681
1,700 Added 4.15%
42,700 $1.23 Million
Q2 2018

Aug 09, 2018

BUY
$21.96 - $39.94 $900,360 - $1.64 Million
41,000 New
41,000 $1.55 Million

Others Institutions Holding QURE

About uniQure N.V.


  • Ticker QURE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,729,100
  • Market Cap $300M
  • Description
  • uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...
More about QURE
Track This Portfolio

Track Swiss National Bank Portfolio

Follow Swiss National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.